Fevipiprant, a DP2 receptor antagonist, inhibits eosinophil migration towards mast cells
Fevipiprant, a DP2 receptor antagonist, inhibits eosinophil migration towards mast cells. Shamri R, Dubois G, Erpenbeck VJ, Mankuta D, Sandham DA, Levi-Schaffer F. Clin Exp Allergy. 2019 Feb;49(2):255-257. doi: 10.1111/cea.13304. Epub 2018 Nov 25. PMID: 30379368
1st EMBRN webinar took place on October 8, 2025. This event highlights exciting new research on mast cells and skin immunity. Thomas Plum was our keynote speaker
Our upcoming EMBRN webinar, scheduled for October 8, 2025. This event will highlight exciting new research on mast cells and skin immunity and is open to all interested researchers
From May 15–17, 2025, the Marcus Maurer Mast Cell Training School took place in Berlin.